INBS
Intelligent Bio Solutions Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Intelligent Bio Solutions (INBS) Stock: Buy, Sell, or Hold?
$2.25
-0.04 (-1.75%)
▼
5d:
+27.12%
30d:
+49.01%
90d:
-11.42%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (24%)
Quality Score
34/100
Position
EXTENDED
30-Day Fair Range
$1.48 – $1.89
Position: EXTENDED
Forward P/E & Valuation
-0.4x
CHEAP
vs 13.0x historical avg
Wall Street Target
$12.00
+433.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.61 / $2.35
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: INBS is 19.0% above its trading range ($1.89). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $2.25, which is considered extended relative to its 30-day fair value range of $1.48 to $1.89. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.4) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INBS is in a downtrend. Immediate support is located at $1.61, while resistance sits at $2.35.
Market Sentiment: INBS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+433.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INBS is in a downtrend. Immediate support is located at $1.61, while resistance sits at $2.35.
Market Sentiment: INBS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+433.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.48 -
$1.89
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Trading Range & Key Levels
30-Day Trading Range
$1.48 -
$1.89
Current vs Trading Range
EXTENDED
Support Level
$1.61
Resistance Level
$2.35
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+19.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 433.3% below Wall St target ($12.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.43
Wall Street Target
$12.00
(+433.3%)
Revenue Growth (YoY)
35.8%
Profit Margin
-294.9%
PE vs Historical
-0.4 vs 13.0
CHEAP
Share INBS Analysis
Share this live INBS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INBS)
Neutral
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards $INBS with no mention of FDA interaction in the latest news.
Key Retail Themes:
Bullish sentiment
Absence of FDA interaction in news
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:29 AM ET
Data refreshes hourly during market hours. Next update: 5:29 AM
Data refreshes hourly during market hours. Next update: 5:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INBS Research Pages